amorphous solid dispersion

Marano, Stefania ORCID: https://orcid.org/0000-0001-7686-2924, Ghimire, Manish, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali, Craig, Duncan Q. M. ORCID: https://orcid.org/0000-0003-1294-8993 and Barker, Susan ORCID: https://orcid.org/0000-0003-4880-0253 (2023) Development of robust tablet formulations with enhanced drug dissolution profiles from centrifugally-spun micro-fibrous solid dispersions of itraconazole, a BCS class II drug. Pharmaceutics, 15 (3):802. pp. 1-28. ISSN 1999-4923 (Online) (doi:10.3390/pharmaceutics15030802)

centrifugal spinning

Marano, Stefania ORCID: https://orcid.org/0000-0001-7686-2924, Ghimire, Manish, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali, Craig, Duncan Q. M. ORCID: https://orcid.org/0000-0003-1294-8993 and Barker, Susan ORCID: https://orcid.org/0000-0003-4880-0253 (2023) Development of robust tablet formulations with enhanced drug dissolution profiles from centrifugally-spun micro-fibrous solid dispersions of itraconazole, a BCS class II drug. Pharmaceutics, 15 (3):802. pp. 1-28. ISSN 1999-4923 (Online) (doi:10.3390/pharmaceutics15030802)

dissolution enhancement

Marano, Stefania ORCID: https://orcid.org/0000-0001-7686-2924, Ghimire, Manish, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali, Craig, Duncan Q. M. ORCID: https://orcid.org/0000-0003-1294-8993 and Barker, Susan ORCID: https://orcid.org/0000-0003-4880-0253 (2023) Development of robust tablet formulations with enhanced drug dissolution profiles from centrifugally-spun micro-fibrous solid dispersions of itraconazole, a BCS class II drug. Pharmaceutics, 15 (3):802. pp. 1-28. ISSN 1999-4923 (Online) (doi:10.3390/pharmaceutics15030802)

itraconazole

Marano, Stefania ORCID: https://orcid.org/0000-0001-7686-2924, Ghimire, Manish, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali, Craig, Duncan Q. M. ORCID: https://orcid.org/0000-0003-1294-8993 and Barker, Susan ORCID: https://orcid.org/0000-0003-4880-0253 (2023) Development of robust tablet formulations with enhanced drug dissolution profiles from centrifugally-spun micro-fibrous solid dispersions of itraconazole, a BCS class II drug. Pharmaceutics, 15 (3):802. pp. 1-28. ISSN 1999-4923 (Online) (doi:10.3390/pharmaceutics15030802)

microfibre

Marano, Stefania ORCID: https://orcid.org/0000-0001-7686-2924, Ghimire, Manish, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali, Craig, Duncan Q. M. ORCID: https://orcid.org/0000-0003-1294-8993 and Barker, Susan ORCID: https://orcid.org/0000-0003-4880-0253 (2023) Development of robust tablet formulations with enhanced drug dissolution profiles from centrifugally-spun micro-fibrous solid dispersions of itraconazole, a BCS class II drug. Pharmaceutics, 15 (3):802. pp. 1-28. ISSN 1999-4923 (Online) (doi:10.3390/pharmaceutics15030802)

oral formulation

Marano, Stefania ORCID: https://orcid.org/0000-0001-7686-2924, Ghimire, Manish, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali, Craig, Duncan Q. M. ORCID: https://orcid.org/0000-0003-1294-8993 and Barker, Susan ORCID: https://orcid.org/0000-0003-4880-0253 (2023) Development of robust tablet formulations with enhanced drug dissolution profiles from centrifugally-spun micro-fibrous solid dispersions of itraconazole, a BCS class II drug. Pharmaceutics, 15 (3):802. pp. 1-28. ISSN 1999-4923 (Online) (doi:10.3390/pharmaceutics15030802)

poorly water-soluble drug

Marano, Stefania ORCID: https://orcid.org/0000-0001-7686-2924, Ghimire, Manish, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali, Craig, Duncan Q. M. ORCID: https://orcid.org/0000-0003-1294-8993 and Barker, Susan ORCID: https://orcid.org/0000-0003-4880-0253 (2023) Development of robust tablet formulations with enhanced drug dissolution profiles from centrifugally-spun micro-fibrous solid dispersions of itraconazole, a BCS class II drug. Pharmaceutics, 15 (3):802. pp. 1-28. ISSN 1999-4923 (Online) (doi:10.3390/pharmaceutics15030802)

sucrose

Marano, Stefania ORCID: https://orcid.org/0000-0001-7686-2924, Ghimire, Manish, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali, Craig, Duncan Q. M. ORCID: https://orcid.org/0000-0003-1294-8993 and Barker, Susan ORCID: https://orcid.org/0000-0003-4880-0253 (2023) Development of robust tablet formulations with enhanced drug dissolution profiles from centrifugally-spun micro-fibrous solid dispersions of itraconazole, a BCS class II drug. Pharmaceutics, 15 (3):802. pp. 1-28. ISSN 1999-4923 (Online) (doi:10.3390/pharmaceutics15030802)

supersaturation

Marano, Stefania ORCID: https://orcid.org/0000-0001-7686-2924, Ghimire, Manish, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali, Craig, Duncan Q. M. ORCID: https://orcid.org/0000-0003-1294-8993 and Barker, Susan ORCID: https://orcid.org/0000-0003-4880-0253 (2023) Development of robust tablet formulations with enhanced drug dissolution profiles from centrifugally-spun micro-fibrous solid dispersions of itraconazole, a BCS class II drug. Pharmaceutics, 15 (3):802. pp. 1-28. ISSN 1999-4923 (Online) (doi:10.3390/pharmaceutics15030802)

tabletting

Marano, Stefania ORCID: https://orcid.org/0000-0001-7686-2924, Ghimire, Manish, Missaghi, Shahrzad, Rajabi-Siahboomi, Ali, Craig, Duncan Q. M. ORCID: https://orcid.org/0000-0003-1294-8993 and Barker, Susan ORCID: https://orcid.org/0000-0003-4880-0253 (2023) Development of robust tablet formulations with enhanced drug dissolution profiles from centrifugally-spun micro-fibrous solid dispersions of itraconazole, a BCS class II drug. Pharmaceutics, 15 (3):802. pp. 1-28. ISSN 1999-4923 (Online) (doi:10.3390/pharmaceutics15030802)